Sequana Medical is pioneering the treatment of drug-resistant fluid overload in liver disease, heart failure and cancer
Sequana Medical is a commercial stage medical device company focused on the development of innovative treatment solutions for the management of liver disease, heart failure, malignant ascites and other fluid imbalance disorders. Sequana Medical’s core markets of liver disease and heart failure are large and growing, driven by unhealthy lifestyles and ageing populations.
CEO
Ian Crosbie
Sub segment
Fluid overload
Location
Ghent, Belgium